EGFR is a major oncogenic promoter in human cancers, especially upon gene amplification and overexpression (Sigismund et al, 2018); however, AS43 do not carry EGFR mutations or elevated expression, so we posited that the presence of G842C‐PlxnB2 might promote its noncanonical activation. This evidence concerns the gene EGFR and cancer.